Loading
A live screen of the small-cap universe ordered by coverage-gap score — a composite of analyst count, last-coverage-change recency, and fundamental signal strength. Filter by cap, exchange, sector, and tier. Every row links to a source-backed profile.
State is in the URL. Share a filtered screen by copying the link.
| Ticker | Name · sector | Cap | ADV | Analysts | Tier | Gap , sorted descending | Why surfaced |
|---|---|---|---|---|---|---|---|
| QORMNASDAQ | Qorm Diagnostics Healthcare | $184M | $0.6M/d | 1 | low coverage | 78 | Single sell-side voice; reimbursement code expansion 2026-Q2 not yet modeled by consensus. |
| KRYONASDAQ | Kryo Storage Healthcare | $168M | $0.7M/d | 1 | low coverage | 76 | Single coverage, governance review opened by audit committee not modeled by sell-side. |
| ZVJWVAMEX | Zephir Pet Consumer | $96M | $0.4M/d | 1 | low coverage | 76 | Regulatory change opens a reimbursement vector the last sell-side note didn't price. |
| GNRBAMEX | Ember Health Healthcare | $30M | $0.0M/d | 2 | low coverage | 75 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| WPGHNYSE | Hexor Sciences Healthcare | $49M | $0.2M/d | 1 | low coverage | 74 | No-coverage screen flag; recent insider buying not yet modeled. |
| NVCTNASDAQ | Novicort Bio Healthcare | $178M | $0.8M/d | 1 | low coverage | 73 | Single coverage and Phase 3 readout post-coverage refresh; consensus has stale model. |
| AFVVOTC | Drayve Therapeutics Healthcare | $72M | $0.5M/d | 1 | low coverage | 72 | Capacity-utilization step-up not present in the prior analyst note's model. |
| MJQJNASDAQ | Westra Therapeutics Healthcare | $284M | $1.0M/d | 1 | low coverage | 72 | Hedge-book mechanics flatter the FCF profile than consensus assumes for this cap bucket. |
| RHXJHNYSE | Yarrow Outdoor Consumer | $213M | $0.2M/d | 1 | low coverage | 72 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| BTHENYSE | Bethel Foods Consumer | $248M | $0.9M/d | 1 | low coverage | 71 | DTC subsegment growing 28% YoY but reported only in aggregate; one analyst, no segment model. |
| REPLNASDAQ | Replion Therapeutics Healthcare | $156M | $0.8M/d | 1 | low coverage | 70 | Catalyst-driven cohort, single coverage, no consensus model post-Phase-2 readout. |
| KSFQAMEX | Orval Mining Materials | $76M | $0.2M/d | 1 | low coverage | 68 | Channel structure obscures sell-through; alt-data flags acceleration. |
| VFUUNASDAQ | Cantil Bio Healthcare | $145M | $0.3M/d | 1 | low coverage | 68 | Tenant credit migration in the latest 10-K not yet flagged by the small-cohort sell-side. |
| HPDMOTC | Ember Properties Real Estate | $360M | $1.1M/d | 1 | low coverage | 66 | Bookings disclosure expanded; consensus model still references the prior format. |
| DCBMANYSE | Synd Brands Consumer | $257M | $0.5M/d | 1 | low coverage | 66 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| CWQWAMEX | Kestrel REIT Real Estate | $50M | $0.2M/d | 1 | low coverage | 65 | Bookings disclosure expanded; consensus model still references the prior format. |
| NAQBNASDAQ | Zephir Foods Consumer | $138M | $0.6M/d | 2 | low coverage | 65 | Sub-coverage cohort with backlog disclosure changing materially since the last analyst note. |
| NBJPZNASDAQ | Zephir Trust Real Estate | $149M | $0.3M/d | 1 | low coverage | 65 | Channel structure obscures sell-through; alt-data flags acceleration. |
| TWEEOTC | Hexor Properties Real Estate | $90M | $0.2M/d | 1 | low coverage | 65 | Combined-ratio improvement on a tiny float; OTC listing keeps it off institutional desks. |
| ATLSNYSE | Atlas Cement Holdings Materials | $612M | $2.1M/d | 2 | low coverage | 64 | Two-coverage cohort, regional infrastructure spend re-rates input prices not yet reflected. |
| NCYTSOTC | Penna Health Healthcare | $293M | $0.9M/d | 1 | low coverage | 64 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| NMARNYSE | Vante Materials Materials | $79M | $0.1M/d | 1 | low coverage | 63 | Capital structure unusually clean for the cohort; no current sell-side voice. |
| QSCLCAMEX | Synd Cement Materials | $179M | $0.5M/d | 1 | low coverage | 63 | Channel structure obscures sell-through; alt-data flags acceleration. |
| MBQNNYSE | Falcrest Trust Real Estate | $633M | $2.3M/d | 1 | low coverage | 63 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| GRMCNYSE | Granite Mountain Copper Materials | $412M | $1.8M/d | 2 | low coverage | 60 | Permitted expansion finalized post last analyst update; LOM extension materially understated. |
| QJDFNASDAQ | Borvel Chemicals Materials | $145M | $0.5M/d | 1 | low coverage | 60 | Permitted expansion finalized after the last analyst update; LOM extension understated. |
| KULSAMEX | Zephir Goods Consumer | $46M | $0.1M/d | 1 | low coverage | 60 | Bookings disclosure expanded; consensus model still references the prior format. |
| RUQLAMEX | Nystra Pet Consumer | $247M | $1.3M/d | 1 | low coverage | 59 | Customer-mix shift disclosed in the most recent annual; consensus has not refreshed. |
| TRDMNYSE | Tridem REIT Real Estate | $388M | $1.5M/d | 2 | low coverage | 55 | Tenant credit migration in FY25 not yet flagged by sell-side cohort. |